对于未经治疗的高血压和并发性失眠障碍的失眠的认知行为疗法:SLEEPRIGHT临床试验
Andrew Sherwood1, Christi Ulmer1, Jade Q Wu1
1Duke University Medical Center, Durham, North Carolina, USA.
Journal of clinical hypertension (Greenwich, Conn.)
|March 12, 2024
概括
用CBT-I治疗失眠可能会降低高血压患者心血管疾病的风险. 这项研究调查了改善睡眠是否会降低血压和其他心血管疾病风险标志物.
科学领域:
- 心脏病学 心脏病学
- 睡眠医学 睡眠医学
- 临床试验 临床试验
背景情况:
- 睡眠不足和失眠与心血管疾病 (CVD) 风险增加有关,包括高血压.
- 美国心脏协会现在承认睡眠不足是心血管疾病的危险因素.
- 目前尚不清楚治疗失眠是否可以减轻这种心血管疾病风险的增加.
研究的目的:
- 评估成功的失眠治疗是否能降低未经治疗的高血压和失眠障碍患者的心血管疾病风险标志物.
- 该SLEEPRIGHT试验旨在确定对失眠的认知行为疗法 (CBT-I) 对心血管健康的影响.
主要方法:
- 一项前性临床试验,涉及150名患有高血压和失眠障碍的参与者.
- 参与者接受了为期6周的失眠认知行为疗法 (CBT-I).
- 主要结局包括24小时门诊血压监测测量的夜间血压和血压下降.
主要成果:
- 该研究评估了失眠严重程度,睡眠质量和心血管疾病风险生物标志物的变化.
- 二次结局包括临床血压,脂质概况,血管内皮功能,动脉硬和交感神经系统活动.
- 数据分析的重点是睡眠改善与心血管疾病风险生物标志物结果之间的关联.
结论:
- 在SLEEPRIGHT试验中,使用CBT-I来研究改善睡眠和降低心血管疾病风险之间的联系.
- 研究结果将澄清治疗失眠是否对高血压患者的心血管健康产生积极影响.
- 结果有助于理解睡眠在管理高血压和预防心血管疾病方面的作用.
相关概念视频
01:27Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
01:19Management of Insomnia
247
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
247
01:14CNS Depressants: Barbiturates and Benzodiazepines
263
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
263
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
166
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
166
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
172
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
172
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K